ABOS
Price
$1.26
Change
+$0.06 (+5.00%)
Updated
Jun 9, 03:20 PM (EDT)
Capitalization
72.69M
70 days until earnings call
EYPT
Price
$8.89
Change
-$0.04 (-0.45%)
Updated
Jun 9, 11:35 AM (EDT)
Capitalization
615.18M
51 days until earnings call
Interact to see
Advertisement

ABOS vs EYPT

Header iconABOS vs EYPT Comparison
Open Charts ABOS vs EYPTBanner chart's image
Acumen Pharmaceuticals
Price$1.26
Change+$0.06 (+5.00%)
Volume$100
Capitalization72.69M
EyePoint Pharmaceuticals
Price$8.89
Change-$0.04 (-0.45%)
Volume$100
Capitalization615.18M
ABOS vs EYPT Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. EYPT commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and EYPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ABOS: $1.20 vs. EYPT: $8.94)
Brand notoriety: ABOS and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 172% vs. EYPT: 113%
Market capitalization -- ABOS: $72.69M vs. EYPT: $615.18M
ABOS [@Biotechnology] is valued at $72.69M. EYPT’s [@Biotechnology] market capitalization is $615.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while EYPT’s TA Score has 6 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 4 bearish.
  • EYPT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а +17.65% price change this week, while EYPT (@Biotechnology) price change was +23.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.61%. For the same industry, the average monthly price growth was +19.48%, and the average quarterly price growth was +6.51%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

EYPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+10.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($615M) has a higher market cap than ABOS($72.7M). EYPT YTD gains are higher at: 20.000 vs. ABOS (-30.233). ABOS has higher annual earnings (EBITDA): -77.89M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. ABOS (200M). EYPT has less debt than ABOS: EYPT (24.1M) vs ABOS (28.5M). EYPT has higher revenues than ABOS: EYPT (56M) vs ABOS (0).
ABOSEYPTABOS / EYPT
Capitalization72.7M615M12%
EBITDA-77.89M-144.55M54%
Gain YTD-30.23320.000-151%
P/E RatioN/AN/A-
Revenue056M-
Total Cash200M318M63%
Total Debt28.5M24.1M118%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSEYPT
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 19 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNDT2.660.13
+5.14%
Conduent
CHRD94.892.89
+3.14%
Chord Energy Corp
TXN192.421.93
+1.01%
Texas Instruments
MDXH2.07-0.01
-0.24%
MDxHealth SA
MLKN17.07-0.05
-0.29%
MillerKnoll

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with LYRA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+8.36%
LYRA - EYPT
58%
Loosely correlated
-4.15%
OCUL - EYPT
57%
Loosely correlated
+6.62%
ATHE - EYPT
54%
Loosely correlated
-1.69%
BEAM - EYPT
54%
Loosely correlated
+9.26%
RXRX - EYPT
53%
Loosely correlated
+20.13%
More